Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 2
1999 1
2000 1
2001 2
2002 2
2003 5
2004 4
2005 2
2006 4
2007 4
2008 7
2009 22
2010 26
2011 22
2012 26
2013 30
2014 23
2015 21
2016 29
2017 30
2018 29
2019 44
2020 47
2021 49
2022 43
2023 31
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

447 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. Among authors: chae dw. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Among authors: chae dw. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Pragmatic Clinical Trials.
Doorenbos AZ, Chae D. Doorenbos AZ, et al. Among authors: chae d. J Korean Acad Nurs. 2022 Oct;52(5):477-478. doi: 10.4040/jkan.22127. J Korean Acad Nurs. 2022. PMID: 36373464 No abstract available.
Diagnosis and Treatment of Inflammatory Joint Disease.
Kim Y, Oh HC, Park JW, Kim IS, Kim JY, Kim KC, Chae DS, Jo WL, Song JH. Kim Y, et al. Among authors: chae ds. Hip Pelvis. 2017 Dec;29(4):211-222. doi: 10.5371/hp.2017.29.4.211. Epub 2017 Dec 1. Hip Pelvis. 2017. PMID: 29250494 Free PMC article. Review.
The KNOW-CKD Study: What we have learned about chronic kidney diseases.
Oh KH, Kang M, Kang E, Ryu H, Han SH, Yoo TH, Kim SW, Chae DW, Lee KB, Park SK, Kim YH, Ahn C; KNOW-CKD Study Investigators. Oh KH, et al. Among authors: chae dw. Kidney Res Clin Pract. 2020 Jun 30;39(2):121-135. doi: 10.23876/j.krcp.20.042. Kidney Res Clin Pract. 2020. PMID: 32550711 Free PMC article. Review.
Model-informed precision dosing in vancomycin treatment.
Yoon S, Guk J, Lee SG, Chae D, Kim JH, Park K. Yoon S, et al. Among authors: chae d. Front Pharmacol. 2023 Oct 9;14:1252757. doi: 10.3389/fphar.2023.1252757. eCollection 2023. Front Pharmacol. 2023. PMID: 37876732 Free PMC article.
447 results